Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Malignant Melanoma

Free Subscription 30.07.2018 1 Am J Dermatopathol 1 Ann Surg Oncol 2 Anticancer Res 1 Br J Cancer 1 Cancer Lett 2 Cancer Res 1 Clin Cancer Res 2 J Am Acad Dermatol 3 J Invest Dermatol 3 Melanoma Res 1 Ophthalmology 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Am J Dermatopathol

1. AL-ZAID T, Salah HT
   Traumatic Neuroma With Melanoma Perineural Invasion.
   Am J Dermatopathol. 2018 Jul 24. doi: 10.1097/DAD.0000000000001231.
   PubMed     Text format     Abstract available
   
   

   
   Ann Surg Oncol

2. SINNAMON AJ, Song Y, Sharon CE, Yang YX, et al
   Prediction of Residual Nodal Disease at Completion Dissection Following Positive Sentinel Lymph Node Biopsy for Melanoma.
   Ann Surg Oncol. 2018 Jul 24. pii: 10.1245/s10434-018-6647.
   PubMed     Text format     Abstract available
   
   

   
   Anticancer Res

3. ARIMOTO A, Yamashita K, Hasegawa H, Sugita Y, et al
   Immunosuppression Induced by Perioperative Peritonitis Promotes Lung Metastasis.
   Anticancer Res. 2018;38:4333-4338.
   PubMed     Text format     Abstract available
   
   
4. TUPY R, Mirka H, Mracek J, Priban V, et al
   Tumor-related Perfusion Changes in White Matter Adjacent to Brain Tumors: Pharmacodynamic Analysis of Dynamic 3T Magnetic Resonance Imaging.
   Anticancer Res. 2018;38:4149-4152.
   PubMed     Text format     Abstract available
   
   

   
   Br J Cancer

5. LIPPLAA A, Fernandes R, Marshall A, Lorigan P, et al
   25-hydroxyvitamin D serum levels in patients with high risk resected melanoma treated in an adjuvant bevacizumab trial.
   Br J Cancer. 2018 Jul 23. pii: 10.1038/s41416-018-0179.
   PubMed     Text format     Abstract available
   
   

   
   Cancer Lett

6. QIU H, Zmina PM, Huang AY, Askew D, et al
   Inhibiting Notch1 enhances immunotherapy efficacy in melanoma by preventing Notch1 dependent immune suppressive properties.
   Cancer Lett. 2018 Jul 20. pii: S0304-3835(18)30482.
   PubMed     Text format     Abstract available
   
   

   
   Cancer Res

7. VISHNOI M, Boral D, Liu H, Sprouse ML, et al
   Targeting USP7 identifies a metastasis-competent state within bone marrow-resident melanoma CTCs.
   Cancer Res. 2018 Jul 19. pii: 0008-5472.CAN-18-0644.
   PubMed     Text format     Abstract available
   
   
8. SHABANEH TB, Molodtsov A, Steinberg SM, Zhang P, et al
   Oncogenic BRAFV600E governs regulatory T cell recruitment during melanoma tumorigenesis.
   Cancer Res. 2018 Jul 19. pii: 0008-5472.CAN-18-0365.
   PubMed     Text format     Abstract available
   
   

   
   Clin Cancer Res

9. JOHNSON DB, Dahlman KB
   Class matters: Sensitivity of BRAF-mutant melanoma to MAPK inhibition.
   Clin Cancer Res. 2018 Jul 24. pii: 1078-0432.CCR-18-1795.
   PubMed     Text format     Abstract available
   
   

   
   J Am Acad Dermatol

10. GARRETT GL, Yuan JT, Shin TM, Arron ST, et al
    Validity of skin cancer malignancy reporting to the Organ Procurement Transplant Network: A cohort study.
    J Am Acad Dermatol. 2018;78:264-269.
    PubMed     Text format     Abstract available
    
    
11. PUZA CJ, Mosca PJ, Cardones AR
    Early Stage Melanoma and Hematopoietic Stem Cell Transplantation Outcomes.
    J Am Acad Dermatol. 2018 Jul 16. pii: S0190-9622(18)32280.
    PubMed     Text format    
    
    

    
    J Invest Dermatol

12. RAMSPOTT JP, Bekkat F, Bod L, Favier M, et al
    Emerging role of IL4-induced gene 1 as a prognostic biomarker affecting the local T cell response in human cutaneous melanoma.
    J Invest Dermatol. 2018 Jul 23. pii: S0022-202X(18)32301.
    PubMed     Text format     Abstract available
    
    
13. PAMPENA R, Pellacani G, Longo C
    Nevus-Associated Melanoma: Patient Phenotype and Potential Biological Implications.
    J Invest Dermatol. 2018;138:1696-1698.
    PubMed     Text format     Abstract available
    
    
14. NOSRATI A, Yu WY, McGuire J, Griffin A, et al
    Outcomes and risk factors in patients with multiple primary melanomas.
    J Invest Dermatol. 2018 Jul 19. pii: S0022-202X(18)32359.
    PubMed     Text format     Abstract available
    
    

    
    Melanoma Res

15. SUN H, Chen Y, Chen Y, Liu D, et al
    Primary malignant melanoma of the cervix: 14 cases and literature overview.
    Melanoma Res. 2018 Jul 23. doi: 10.1097/CMR.0000000000000469.
    PubMed     Text format     Abstract available
    
    
16. AYDOGMUS-OZTURK F, Gunaydin K, Ozturk M, Jahan H, et al
    Effect of Sideritis leptoclada against HT-144 human malignant melanoma.
    Melanoma Res. 2018 Jul 19. doi: 10.1097/CMR.0000000000000487.
    PubMed     Text format     Abstract available
    
    
17. SAGLAM O, Naqvi SMH, Zhang Y, Mesa T, et al
    Female genitourinary tract melanoma: mutation analysis with clinicopathologic correlation: a single-institution experience.
    Melanoma Res. 2018 Jul 19. doi: 10.1097/CMR.0000000000000480.
    PubMed     Text format     Abstract available
    
    

    
    Ophthalmology

18. JAGER MJ, Brouwer NJ, Esmaeli B
    The Cancer Genome Atlas Project: An Integrated Molecular View of Uveal Melanoma.
    Ophthalmology. 2018;125:1139-1142.
    PubMed     Text format    
    
    

    
    PLoS One

19. LADDS MJGW, Pastor-Fernandez A, Popova G, van Leeuwen IMM, et al
    Autophagic flux blockage by accumulation of weakly basic tenovins leads to elimination of B-Raf mutant tumour cells that survive vemurafenib.
    PLoS One. 2018;13:e0195956.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Malignant Melanoma is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: